Overview / Abstract: |
Target Audience This activity is intended for neurologists, psychiatrists, nurse practitioners, physician assistants, and other health care professionals involved in the management of PBA. Program Overview Pseudobulbar affect is characterized by sudden and uncontrollable outbursts of crying or laughter that are out of context with an individual’s mood or situation. The psychological consequences around family members and in social situations can be substantial, leading to isolation and depression. As a relatively rare condition, PBA is frequently misdiagnosed or underdiagnosed. Underlying neurological conditions, most commonly multiple sclerosis, amyotrophic lateral sclerosis, stroke, and traumatic brain injuries, are associated with pseudobulbar affect. Although antidepressants have been used with little evidence to treat symptoms of PBA, the approved combination therapy of dextromethorphan hydrobromide/quinidine sulfate provides significant relief to patients with PBA. To enable earlier diagnosis and treatment of pseudobulbar affect, this 2-part Provider and Caregiver Connection™ first provides expert audio commentary and text overview of clinical aspects of pseudobulbar affect. Patient and caregiver perspectives are then provided in a panel-style discussion with faculty who cover the burden on quality of life, challenges of diagnosis, and effective treatment. Learning Objectives Upon successful completion of this educational activity, you should be better prepared to: Delineate the key symptoms of PBA and its burden on patients and their caregivers |
Expiration |
Mar 27, 2021 |
Discipline(s) |
Nursing CNE, Physician CME |
Format |
Online |
Credits / Hours |
1.5 AMA PRA Category 1 Credit(s)™ |
Accreditation |
ACCME |
Presenters / Authors / Faculty |
Gerald A. Maguire, MD William M. Sauvé, MD James Wymer, MD, Ph.D |
Sponsors / Supporters / Grant Providers |
Avanir Pharmaceuticals |
Keywords / Search Terms |
Relias LLC Relias LLC., FREE CME. Free CE CME |